Figure 3.

Alpha-camera image of the heterogeneous intra-tumoral activity distribution (A) and dose rate image with isodose curves (in mGy/s/MBq) for different intervals from low (black; 0.08 - 0.12) to high (red; 0.30 - 1.09) (B) of an ²¹¹At-labeled antibody fragment targeting NaPi2B in an OVCAR-3 tumor slices. This research was originally published in JNM. Bäck et al. Cure of human ovarian carcinoma solid xenografts by fractionated α-radioimmunotherapy with ²¹¹At-MX35-F(ab')₂: influence of absorbed tumor dose and effect on long-term survival. J Nucl Med. 2017;58:598-604. ⁸³ © SNMMI.